HomeMedication lookupDrug classes › Antipsychotics
Antipsychotics

Antipsychotics and pharmacogenetics

Also known as: Neuroleptics

7 medications 7 brand products CYP2D6CYP1A2CYP3A5

Why pharmacogenetics matter for antipsychotics

Antipsychotics treat schizophrenia, bipolar disorder, severe depression (as augmentation), and several other conditions. Modern antipsychotics mostly clear through CYP2D6 and CYP3A4, with smaller contributions from CYP1A2. Aripiprazole, brexpiprazole, iloperidone, and pimozide all have FDA label guidance for CYP2D6 poor metabolizers. Clozapine is unusual in being CYP1A2-dominant, which is why smoking status interacts so strongly with clozapine dosing.

Akathisia, extrapyramidal symptoms, and metabolic side effects from antipsychotics are often dose-related, which is where pharmacogenetic testing can have the largest impact on tolerability.

Key genes in this class

Medications in this class with pharmacogenetic guidelines

Each link goes to the drug's full pharmacogenetics page with CPIC and FDA phenotype recommendations.

Brand products in the Antipsychotics class

Combined products and brand names for the medications above. Each links to a pharmacogenetic breakdown.

Which antipsychotics is right for your genetics?

This page covers the pharmacogenetics of antipsychotics in general. A Gene2Rx report tells you how your personal genotype interacts with every drug on this page.

Get your report Look up a medication

Informational only, not medical advice. Pharmacogenetic guidelines describe population-level patterns that inform prescribing decisions. Never start, stop, or change a medication without talking to your prescribing clinician.

Get Your Report Now
Ready in One Minute